Detection of low HIV-1 RNA levels in plasma

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 14, Issue 2, 1997, Pages 179-183

  Schockmel, Gérard A ^a   Yerly, Sabine ^a   Perrin, Luc ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

HIV 1 RNA; HIV 1 viremia; PCR

Indexed keywords

VIRUS RNA;

ARTICLE; DIAGNOSTIC ACCURACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS DETECTION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0031056598     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199702010-00013     Document Type: Article

References (20)

1. Collier AC, Coombs RW, Schoenfeld DA, et al. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. N Engl J Med 1996;334:1011-7.
2. Markowitz M, Saag M, Powderly WG, et al. A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-I infection. N Engl J Med 1995;333:1534-9.
3. + cells per cubic millimeter. North American HIV Working Party [see comments]. N Engl J Med 1995; 333:1662-9.
4. Perrin L, Yerly S, Charvier A, Figueras G, Schockmel GA, Hirschel B. Zidovudine plus didanosine in primary HIV infection. Antiviral Therapy (in press).
5. Perrin L, Rakik A, Yerly S, Baumberger C, Kinloch-de-Loes S, Pechère M, Hirschel B. Combined therapy with zidovudine and L-697,661 in primary HIV infection. AIDS (In press).
6. Gulick R, Mellors J, Havlir D, et al. Potent and sustained antiretroviral activity of indinavir (IDV) in combination with zidovudine (ZDV) and lamivudine (3TC) [abstract]. 3rd Conference on Retroviruses and Opportunistic Infections, Washington DC, 1996.
7. Massari F, Conant M, Mellors J, et al. A phase II open-label, randomized study of the triple combination of indinavir, zidovudine (ZDV) and didanosine (DDI) versus indinavir alone and zidovudine/didanosine in antiretroviral naive patients [abstract]. 3rd Conference on Retroviruses and Opportunistic Infections, Washington DC, 1996.
8. Revets H, Marissens D, De Wit S, Lacor P, Clumeck N, Lauwers S, Zissis G. Comparative evaluation of NASBA HIV-1 RNA QT, AMPLICOR-HIV monitor, and QUANTIPLEX HIV RNA assay, three methods for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 1996;34:1058-64.
9. Mulder J, McKinney N, Christopherson C, Sninsky J, Greenfield L, Kwok S. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J Clin Microbiol 1994;32:292-300.
10. Myers TW, Gelfand DH. Reverse transcription and DNA amplification by a Thermus thermophilus DNA polymerase. Biochemistry 1991;30:7661-6.
11. Loeffelholz MJ, Lewinski CA, Silver SR, Purohit AP, Herman SA, Buonagurio DA, Dragon EA. Detection of Chlamydia trachomatis in endocervical specimens by polymerase chain reaction. J Clin Microbiol 1992;30:2847-51.
12. Ioannidis JPA, Cappelleri JC, Lau J, Sacks HS, Skolnik PR. Predictive value of viral load measurements in asymptomatic untreated HIV-1 infection: a mathematical model. AIDS 1996;10:255-62.
13. Haubrich RH, Flexner C, Lederman M, et al. Quantitation of HIV RNA measured by reverse transcription PCR (RT PCR) as a marker of activity of antiviral therapy [abstract 337]. 2nd National Conference on Human Retroviruses and Related Infections. Washington, DC, January-February 1995.
14. Mellors JW, Rinaldo CR, Gupta P, White RM, Todd JA. Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-70.
15. Galetto-Lacour A, Yerly S, Perneger TV, Baumberger C, Hirschel B, Perrin L; the Swiss HIV Cohort Study Group. Prognostic value of viremia in patients with long-standing human immunodeficiency virus infection. J Infect Dis 1996;173: 1388-93.
16. Yerly S, Kaiser L, Mermillod B, Baumberger C, Hirschel B, Perrin L. Response of HIV RNA to didanosine as a predictive marker of survival. AIDS 1995;9:159-63.
17. Loveday C, Hill A. Prediction of progression to AIDS with serum HIV-I RNA and CD4 count [letter]. Lancet 1995; 345:790-1.
18. Jurriaans S, Weverling GJ, Goudsmit J, et al. Distinct changes in HIV type 1 RNA versus p24 antigen levels in serum during short-term zidovudine therapy in asymptomatic individuals with and without progression to AIDS. AIDS Res Hum Retroviruses 1995;11:473-9.
19. Havlir D, Cheeseman SH, McLaughlin M, et al. High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection. J Infect Dis 1995;171:537-45.
20. Volberding PA. HIV quantification: clinical applications. Lancet 1996;347:71-3.